Michel: The EU will not allow pharmaceutical companies to supply vaccines as agreed



[ad_1]

What you need to know in 2021, every morning.

The European Union will fulfill its contractual obligations to coronavirus vaccine manufacturers, Charles Michel, president of the European Council, told French radio Europe 1 on Sunday.

US pharmaceutical company Pfizer announced last week that it will slow vaccine shipments to increase manufacturing capacity. On Friday, the British company AstraZeneca announced that production of the vaccine to the EU will also slow down due to manufacturing problems.

“Using our legal means, we will make sure that the manufacturers respect the terms of the contract,” said Michel. The EU insists that companies communicate transparently about the causes of late deliveries. He also said that when Pfizer realized that a delay was expected, the EU had managed to reduce the length of the delays, taking a tough negotiating position.

“We hit the table hard, reducing the delay,” he said, emphasizing that pharmaceutical companies have since agreed to ship to the European Union on the original schedule starting the week of January 25.

Michel also spoke about the fact that Pfizer cited, among other things, as a reason for the slowdown in delivery which turned out that not only 5 but 6 doses of vaccine could be drawn from a vaccine vial. And according to the pharmaceutical company, they have hired the EU not by vials but by dose, so they don’t need as many vials. The politician said he expects Pfizer to speak transparently and clearly and agree with the European Medicines Agency on the exact volume of the second shipment of vaccine, both in terms of vials and doses. (Europe1, MTI)



[ad_2]